Donald Trump sends a vaguely worded love letter to biopharma as stock rally continues
The big biopharma stock rally continued to percolate through Day Two of the aftermath of Donald Trump’s election. And that wasn’t hurt in the least by the president-elect’s promise to reform the FDA once he gets into office, 70 days from now.
Trump’s post-election mission statement for his administration on healthcare — posted at greatagain.gov — starts with the repeal of Obamacare and goes on to make a couple of vague promises that may well spell new benefits for the industry. Included in that roster:
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.